Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES AUROBINDO PHARMA DIVIS LABORATORIES/
AUROBINDO PHARMA
 
P/E (TTM) x 31.4 12.1 260.4% View Chart
P/BV x 6.4 1.0 614.9% View Chart
Dividend Yield % 1.1 2.1 51.5%  

Financials

 DIVIS LABORATORIES   AUROBINDO PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
AUROBINDO PHARMA
Mar-22
DIVIS LABORATORIES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4251,064 510.0%   
Low Rs3,562584 609.7%   
Sales per share (Unadj.) Rs337.5400.3 84.3%  
Earnings per share (Unadj.) Rs111.545.7 244.0%  
Cash flow per share (Unadj.) Rs123.364.9 189.8%  
Dividends per share (Unadj.) Rs30.009.00 333.3%  
Avg Dividend yield %0.71.1 61.1%  
Book value per share (Unadj.) Rs441.8419.4 105.3%  
Shares outstanding (eoy) m265.47585.94 45.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.32.1 646.8%   
Avg P/E ratio x40.318.0 223.5%  
P/CF ratio (eoy) x36.512.7 287.3%  
Price / Book Value ratio x10.22.0 517.7%  
Dividend payout %26.919.7 136.6%   
Avg Mkt Cap Rs m1,192,890482,799 247.1%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46234,509 27.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598234,555 38.2%  
Other income Rs m1,1593,226 35.9%   
Total revenues Rs m90,757237,781 38.2%   
Gross profit Rs m38,81142,566 91.2%  
Depreciation Rs m3,11511,265 27.7%   
Interest Rs m20486 4.1%   
Profit before tax Rs m36,83534,040 108.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2317,256 99.6%   
Profit after tax Rs m29,60526,784 110.5%  
Gross profit margin %43.318.1 238.7%  
Effective tax rate %19.621.3 92.1%   
Net profit margin %33.011.4 289.4%  
BALANCE SHEET DATA
Current assets Rs m96,104181,227 53.0%   
Current liabilities Rs m24,54481,560 30.1%   
Net working cap to sales %79.942.5 188.0%  
Current ratio x3.92.2 176.2%  
Inventory Days Days925 34.8%  
Debtors Days Days98762 1,581.5%  
Net fixed assets Rs m50,087155,104 32.3%   
Share capital Rs m531586 90.6%   
"Free" reserves Rs m116,751245,174 47.6%   
Net worth Rs m117,282245,760 47.7%   
Long term debt Rs m02,492 0.0%   
Total assets Rs m146,191336,331 43.5%  
Interest coverage x1,842.871.0 2,596.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.7 87.9%   
Return on assets %20.38.1 249.9%  
Return on equity %25.210.9 231.6%  
Return on capital %31.413.9 225.9%  
Exports to sales %031.1 0.0%   
Imports to sales %19.711.9 165.5%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs m17,67627,965 63.2%   
Fx inflow Rs m78,44577,245 101.6%   
Fx outflow Rs m17,95331,524 57.0%   
Net fx Rs m60,49245,721 132.3%   
CASH FLOW
From Operations Rs m19,11850,165 38.1%  
From Investments Rs m-21,949-32,116 68.3%  
From Financial Activity Rs m-5,324-29,693 17.9%  
Net Cashflow Rs m-8,156-11,674 69.9%  

Share Holding

Indian Promoters % 51.9 48.8 106.5%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 35.8 37.2 96.3%  
FIIs % 15.2 22.3 67.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 48.2 99.8%  
Shareholders   414,847 369,828 112.2%  
Pledged promoter(s) holding % 0.0 17.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Aurobindo Pharma Share Price Performance

Period Divis Laboratories Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.22% -1.67% 0.08%
1-Month -18.06% -0.86% -3.10%
1-Year -34.55% -33.21% -8.33%
3-Year CAGR 10.73% -6.89% 16.46%
5-Year CAGR 22.76% -5.80% 9.41%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Flat as Metal Stocks Fall | Adani Group Stocks Slump 10% | Tata Motors, Maruti Top Losers Sensex Today Trades Flat as Metal Stocks Fall | Adani Group Stocks Slump 10% | Tata Motors, Maruti Top Losers(10:30 am)

Asian share markets tracked Wall Street lower today, as a number of Federal Reserve speakers echoed Chair Jerome Powell in saying that interest rates are set to go higher, capping risk sentiment.